1 Min Read
Oct 30 (Reuters) - Macrogen Inc :
* Says it plans to sell its entire 1.6 million shares of MG MED, Inc., a molecular diagnosis company, for 22.61 billion won
Source text in Korean: goo.gl/DbgBiP
Further company coverage: (Beijing Headline News)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.